DE69212011T2 - Endothelin Antagoniste - Google Patents

Endothelin Antagoniste

Info

Publication number
DE69212011T2
DE69212011T2 DE69212011T DE69212011T DE69212011T2 DE 69212011 T2 DE69212011 T2 DE 69212011T2 DE 69212011 T DE69212011 T DE 69212011T DE 69212011 T DE69212011 T DE 69212011T DE 69212011 T2 DE69212011 T2 DE 69212011T2
Authority
DE
Germany
Prior art keywords
salt
peptide
amino acid
carbon atoms
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69212011T
Other languages
English (en)
Other versions
DE69212011D1 (de
Inventor
Mitsuhiro Wakimasu
Takashi Kikuchi
Kazuki Kubo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of DE69212011D1 publication Critical patent/DE69212011D1/de
Publication of DE69212011T2 publication Critical patent/DE69212011T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57536—Endothelin, vasoactive intestinal contractor [VIC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE69212011T 1991-02-15 1992-02-14 Endothelin Antagoniste Expired - Fee Related DE69212011T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2222091 1991-02-15
JP33723591 1991-12-19

Publications (2)

Publication Number Publication Date
DE69212011D1 DE69212011D1 (de) 1996-08-14
DE69212011T2 true DE69212011T2 (de) 1997-01-09

Family

ID=26359402

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69212011T Expired - Fee Related DE69212011T2 (de) 1991-02-15 1992-02-14 Endothelin Antagoniste

Country Status (7)

Country Link
US (1) US5352659A (de)
EP (1) EP0499266B1 (de)
AT (1) ATE140236T1 (de)
CA (1) CA2061246A1 (de)
DE (1) DE69212011T2 (de)
ES (1) ES2089256T3 (de)
GR (1) GR3020961T3 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962490A (en) 1987-09-25 1999-10-05 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
CA2043741C (en) * 1990-06-07 2003-04-01 Kiyofumi Ishikawa Endothelin antagonistic peptide derivatives
US5736509A (en) * 1990-12-14 1998-04-07 Texas Biotechnology Corporation Cyclic peptide surface feature mimics of endothelin
US5352659A (en) * 1991-02-15 1994-10-04 Takeda Chemical Industries Endothelin analogs and uses thereof
EP0547317A1 (de) * 1991-12-19 1993-06-23 Takeda Chemical Industries, Ltd. Endothelin Antagonisten
US5614497A (en) * 1991-12-27 1997-03-25 Takeda Chemical Industries, Ltd. Peptide, production and use thereof
FR2687156B1 (fr) * 1992-02-12 1994-04-01 Roussel Uclaf Nouveaux derives peptidiques, procede de preparation et application a titre de medicaments de ces nouveaux derives.
EP0626174A3 (de) 1993-04-21 1996-01-03 Takeda Chemical Industries Ltd Verfahren und Zusammensetzung für die Prophylaxe und/oder Behandlung von Organunterfunktion.
US6342610B2 (en) 1993-05-20 2002-01-29 Texas Biotechnology Corp. N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US6541498B2 (en) 1993-05-20 2003-04-01 Texas Biotechnology Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6030991A (en) * 1993-05-20 2000-02-29 Texas Biotechnology Corp. Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6376523B1 (en) 1994-05-20 2002-04-23 Texas Biotechnology Corporation Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6613804B2 (en) 1993-05-20 2003-09-02 Encysive Pharmaceuticals, Inc. Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
WO1995000546A1 (fr) * 1993-06-25 1995-01-05 Kyowa Hakko Kogyo Co., Ltd. Peptide a effet antagoniste de l'endotheline
US5977117A (en) 1996-01-05 1999-11-02 Texas Biotechnology Corporation Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin
US5958905A (en) 1996-03-26 1999-09-28 Texas Biotechnology Corporation Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin
US5804585A (en) * 1996-04-15 1998-09-08 Texas Biotechnology Corporation Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
DE19652374A1 (de) * 1996-12-04 1998-06-10 Schering Ag Verwendung von Endothelin-Konjugaten in der Therapie, neue Endothelin-Konjugate, diese enthaltende Mittel, sowie Verfahren zu deren Herstellung
HU227183B1 (en) 1997-04-28 2010-09-28 Encysive Pharmaceuticals Inc Sulfonamide derivatives and pharmaceutical compositions containing them for the treatment of endothelin-mediated disorders
US5783705A (en) * 1997-04-28 1998-07-21 Texas Biotechnology Corporation Process of preparing alkali metal salys of hydrophobic sulfonamides
CA2368431C (en) 1999-03-29 2006-01-24 The Procter & Gamble Company Melanocortin receptor ligands
US7566452B1 (en) 1999-05-04 2009-07-28 New York University Cancer treatment with endothelin receptor antagonists
CA2395684C (en) 1999-12-31 2012-01-03 Texas Biotechnology Corporation Sulfonamides and derivatives thereof that modulate the activity of endothelin
US20050175667A1 (en) * 2004-02-10 2005-08-11 Wenda Carlyle Use of endothelin antagonists to prevent restenosis
WO2007106494A2 (en) * 2006-03-13 2007-09-20 Encysive Pharmaceuticals, Inc. Methods and compositions for treatment of diastolic heart failure
RU2008136315A (ru) * 2006-03-13 2010-04-20 Инсайсив Фармасьютикалз, Инк. (US) Композиции ситаксентана натрия
CA2648385C (en) 2006-04-04 2020-09-01 Singulex, Inc. Highly sensitive system and methods for analysis of troponin
US7838250B1 (en) 2006-04-04 2010-11-23 Singulex, Inc. Highly sensitive system and methods for analysis of troponin
US20080026061A1 (en) * 2006-06-22 2008-01-31 Reichwein John F Crystalline N-(4-chloro-3-methyl-5-isoxazolyl)-2-[2-methyl-4.5-(methylenedioxy)phenylacetyl]-thiophene-3-sulfonamide
WO2010144358A1 (en) 2009-06-08 2010-12-16 Singulex, Inc. Highly sensitive biomarker panels

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8919726D0 (en) * 1989-08-31 1989-10-11 Fujisawa Pharmaceutical Co Ws7338 substances and preparation thereof
CA2032559C (en) * 1989-12-28 2001-11-06 Kiyofumi Ishikawa Endothelin antagonistic cyclic pentapeptides
US5306808A (en) * 1990-02-26 1994-04-26 Takeda Chemical Industries, Ltd. Peptide derivatives having vasodilating activity
US5352659A (en) * 1991-02-15 1994-10-04 Takeda Chemical Industries Endothelin analogs and uses thereof

Also Published As

Publication number Publication date
EP0499266B1 (de) 1996-07-10
ATE140236T1 (de) 1996-07-15
CA2061246A1 (en) 1992-08-16
DE69212011D1 (de) 1996-08-14
US5352659A (en) 1994-10-04
ES2089256T3 (es) 1996-10-01
GR3020961T3 (en) 1996-12-31
EP0499266A1 (de) 1992-08-19

Similar Documents

Publication Publication Date Title
DE69212011T2 (de) Endothelin Antagoniste
GR860023B (en) Method for the preparation of peptidic derivatives with a azote polycyclic structure
ES2032749T3 (es) Acidos oxoftalazinil-aceticos heterociclicos.
AU3756497A (en) D-enzyme compositions and methods of their use
ATE174604T1 (de) Lipopeptide aus actinoplanes sp. mit pharmakologischer wirkung, verfahren zu ihrer herstellung und verwendung derselben
GR3018096T3 (en) Polypeptide comprising repeated cell-adhesive core sequences.
EA199800280A1 (ru) Новые производные 5-0-дезозаминил-6-0-метилэритронолида а, способ их получения и их использование при получении биологически активных продуктов
UA39920C2 (uk) Аналоги 15-дезоксиспергуаліну або їх солі, що мають імуносупресивну активність, спосіб їх отримання та фармацевтична композиція на їх основі
ES2082393T3 (es) Composicion de lavado a base de aceite de sintesis y procedimiento que la emplea.
EP0346927A3 (de) N-substituierte 3-Piperidin-carbonsäure oder N-substituierte 3-Pyridin-carbonsäure und ihre Derivate
ATE151413T1 (de) Verfahren zur racemattrennung von verapamil
TW328948B (en) Composition and process for the synthesis of oxysulphide-containing fluorine-containing organic derivatives
KR850008157A (ko) 아미노산 및 이 에스테르의 n-아실유도체의 제조방법
DE3578423D1 (de) Neue cephalosporine und verfahren zu ihrer herstellung.
ATE119516T1 (de) In stellung 3 durch eine halogenierte gesättigte kette substituierte 2,2- dimethylcyclopropancarbonsäurederivate, verfahren zu deren herstellung und deren verwendung zur herstellung von pestiziden produkten.
NO891481D0 (no) Anvendelse av jordalkalisalter av polykarboksylsyremonoestere som alkoksyleringskatalysatorer.
DE69011677T2 (de) Verfahren zur herstellung von substituierten ethenen.
ATE200776T1 (de) Verfahren zur herstellung von 2,4,5-tribrompyrrol-3-carbonitril
AP9901566A0 (en) Novel erythromycin derivatives, method of preparation and application as medicines.
EP0535448A3 (en) Process and intermediates for the preparation of an antiviral agent containing a cyclobutyl group
ATE175199T1 (de) Verfahren zur herstellung von 2-substituierten 5- chlorimidazol-4-carbaldehyden
ATE119913T1 (de) Thymopentin-analoge mit allen umgekehrten verbindungen, verfahren zur deren herstellung und deren verwendung zur herstellung von pharmazeutischen zusammensetzungen.
EP0331756A4 (en) Agents for prophylaxis and treatment of thrombopenia
EP0294126A3 (de) Mischung auf der Basis halogenhaltiger Harze
AT383811B (de) Verfahren zur herstellung von monoalkalisalzen von 7-amino-3-cephem-4-carbonsaeurederivaten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: TAKEDA PHARMACEUTICAL CO. LTD., OSAKA, JP

8339 Ceased/non-payment of the annual fee